Medigard selects site for trials
Thursday, 10 July, 2008
Medical device company Medigard [ASX; MGZ] will conduct clinical trials of its proprietary safety blood collection devices at Griffith University's Gold Coast campus.
The trials will be held at the university's Genomics Research Centre. 500 of the devices have been delivered to the centre for simulated clinical trials.
The trials are part of the company's FDA 510(k) application, a fast-tracking process for important, innovative or advanced medical devices.
Ultra-processed foods linked to poor health, premature death
Evidence suggests a dose-response relationship between ultra-processed food consumption and...
Shorter radiotherapy course proves safe for prostate cancer
A significantly shorter course of radiotherapy for localised prostate cancer is just as safe and...
5-in-1 meningococcal vaccine proves effective
A life-saving meningococcal vaccine covering all five common strains of the deadly disease could...
